ASX CODE: PCK

PainChek ASX PCK Allium Healthcare Singapore dementia

PainChek gets Singapore regulatory clearance, signs landmark deal with nation’s leading aged care provider

Australian medical device company PainChek (ASX: PCK) has advanced its international expansion strategy with receipt of a key regulatory clearance from Singapore’s Health Sciences...
PainChek ASX PCK Murdoch Children’s Research Institute trial pain app infants

PainChek partners with Australia’s largest child health research institute to trial pain app in infants

As part of its plan to expand its PainChek app to children worldwide, PainChek (ASX: PCK) has teamed up with the Melbourne Murdoch Children’s...
Painchek ASX PCK UK market Person Centred Software

PainChek expands internationally with Person Centred Software UK distribution agreement

PainChek (ASX: PCK) has secured a binding distribution agreement with Person Centred Software paving the way for the company to launch its pain assessment...
Federal Government PainChek Australia ASX PCK grant dementia app

Federal Government to invest $5m in PainChek’s app for dementia patients

Australian medical device company PainChek (ASX: PCK) is set to receive a $5 million grant from the Australian Federal Government to trial its pain...
PainChek ASX PCK Churches of Christ in Queensland residential aged care

PainChek signs licence agreement with Queensland aged care provider

Digital health company PainChek (ASX: PCK) has executed a licence agreement with Churches Of Christ in Queensland, which will give the aged care provider...
PainChek ASX PCK ePAT peer-reviewed study

PainChek receives ePAT validation in peer-reviewed study

PainChek’s (ASX: PCK) proprietary pain-detection product has been officially validated by a peer-reviewed study and in added support towards its overall clinical usefulness in...
PainChek ASX PCK app detects pain AI analyse facial micro-expressions

PainChek to secure FDA De Novo classification

Formerly ePat Technologies (ASX: EPT), medical device company PainChek (ASX: PCK) is on course to secure De Novo classification from the Food and Drug...

RECENT POSTS

STOCK SUMMARY

HOT TOPICS

TRENDING POSTS